Brain Diseases, Brain Infarction, Brain Ischemia, Central Nervous System Diseases, Cerebral Infarction, Cerebrovascular Accident, Cerebrovascular Disorders, Nervous System Diseases, Stroke, Vascular Diseases
Conditions
Keywords
Exercise, Rehabilitation, Dose, Randomized controlled trial, Stroke
Brief summary
The investigators will conduct a proof-of-concept study to provide preliminary evidence of efficacy of physical exercise dose on ambulatory function in adults undergoing sub-acute stroke rehabilitation.
Detailed description
Participants admitted for stroke rehabilitation will be randomly assigned to either the Stroke Management Group, Stroke Monitoring Group or Stroke Supplementary Group. All three groups will receive usual care, in addition to the intervention. The Stroke Management Group will be provided with periodic information about their progress in the area of mobility using specialized activity monitors. The Stroke Monitoring Group will be progressed according to customized protocols using feedback from specialized activity monitors. The Stroke Supplementary Group will receive the same as the Stroke Monitoring Group, but will also receive one additional hour of daily (5 times per week) physical exercise
Interventions
Participants will have usual care, and in addition, be provided with periodic information about their progress in the area of mobility using specialized activity monitors
Participants will have usual care, and in addition, be progressed according to customized protocols using feedback from specialized activity monitors
Participants will have usual care, and in addition, will receive the same as the Stroke Monitoring Group, and also receive one additional hour of daily (5 times per week) physical exercise
Sponsors
Study design
Eligibility
Inclusion criteria
* Have been admitted to a hospital unit for stroke rehabilitation * Within 10 weeks post-stroke * 19 years or older * Are experiencing difficulty walking
Exclusion criteria
* Requires greater than one person assist for transfer or ambulation * Have uncontrolled medical condition or another serious medication condition in addition to stroke * Unable to understand or follow directions
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Ambulatory function measured by the Six Minute Walk Test | Rehabilitation discharge (average 4-5 weeks post admission) |
Secondary
| Measure | Time frame |
|---|---|
| Ambulatory function from the 5 Meter Walk Test | Rehabilitation discharge (average 4-5 weeks post admission) , 6 and 12 months post-stroke |
| Balance function from the Berg Balance Scale | Rehabilitation discharge (average 4-5 weeks post admission), 6 and 12 months post-stroke |
| Ambulatory function from the Functional Ambulation Classification | Rehabilitation discharge (average 4-5 weeks post admission), 6 and 12 months post-stroke |
| Quality of life measured with EuroQol | Rehabilitation discharge (average 4-5 weeks post admission), 6 and 12 months post-stroke |
| Cognition measured by the Montreal Cognitive Assessment | Rehabilitation discharge (average 4-5 weeks post admission), 6 and 12 months post-stroke |
| Ambulatory Function from the Six Minute Walk Test | 6 and 12 months post-stroke |
| Cognition measured by the Trail Making Test | Rehabilitation discharge (average 4-5 weeks post admission), 6 and 12 months post-stroke |
| Depression measured by Patient Health Questionnaire-9 | Rehabilitation discharge (average 4-5 weeks post admission) , 6 and 12 months post-stroke |
| Heart rate measured during the intervention sessions | From 10 intervention sessions within the 4-week intervention |
| Step count measured during the intervention sessions | From 10 intervention sessions within the 4-week intervention |
| Cognition measured by the Digit Symbols Substitution Test | Rehabilitation discharge (average 4-5 weeks post admission) , 6 and 12 months post-stroke |
Countries
Canada